What is the generic form of Lipitor called?
atorvastatin
29, 2011 — The cholesterol-lowering drug Lipitor — the best-selling prescription drug in world history — will be available as a generic drug beginning Nov. 30. Lipitor’s generic name is atorvastatin.
Is generic atorvastatin the same as Lipitor?
Simply put, brand-name Lipitor and generic atorvastatin are the same medication, and, because of that, each is just as safe and effective as the other. Lipitor is made by Pfizer and generic Lipitor, which was first available in November 2011, is made by many different companies.
Is pravastatin as strong as Lipitor?
Pravachol (pravastatin) Lipitor (atorvastatin) improves your cholesterol levels and is a common first treatment for people with high cholesterol or heart disease. Lowers cholesterol. Pravachol (pravastatin) can improve cholesterol, but it’s not as strong as other statin medicines.
Is pravastatin generic for Lipitor?
Lipitor (atorvastatin) and Pravachol (pravastatin) are HMG-CoA reductase inhibitors (“statins” used to treat elevated total cholesterol, LDL, triglycerides, and to elevate HDL cholesterol. Side effects of Lipitor and Pravachol that are similar include diarrhea, nausea, headache, or muscle pain.
Which is better atorvastatin or Lipitor?
Atorvastatin is the generic version of the brand name drug Lipitor. Both are available as an oral tablet that is taken once per day. Research has found no significant difference in clinical outcomes between the two versions of the medication.
Is pravastatin hard on your liver?
You may wonder about the cholesterol medications known as statins and whether they can hurt your liver. While atorvastatin, simvastatin, lovastatin, and pravastatin can frequently affect liver function blood tests, they do not tend to cause concerning liver damage.
How much will 10 mg of pravastatin lower cholesterol?
The dosage consisted of 10 mg of pravastatin daily during the 6-month trial. Over that period, in the pravastatin group, plasma levels of total cholesterol and LDL-cholesterol significantly (P < . 01) dropped (-20% and -25%, respectively) compared to the placebo group.